<DOC>
	<DOCNO>NCT00543738</DOCNO>
	<brief_summary>A study test effect MK0767 add Metformin patient inadequately control Type 2 Diabetes Mellitus . This early phase trial specific protocol information progress publicly available time . ( Full information available trial participant ) .</brief_summary>
	<brief_title>MK0767 Metformin Combination Study ( 0767-028 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>All woman childbearing potential must negative urine pregnancy test prior start study Patients must stable dose metformin least 2 week prior visit 2 Patients history type 1 diabetes mellitus and/or history ketoacidosis Patients estrogen replacement therapy regimen SERM Patients history , allergy , intolerance hypersensitivity statins fibric acid derivative , include history elevate muscle liver function test , jaundice , hepatoxicity , myopathy associate treatment Patient weight loss program ongoing weight loss start intensive exercise program within 4 week start study Have active liver gall bladder disease HIV positive</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>